Related references
Note: Only part of the references are listed.Spike mutation D614G alters SARS-CoV-2 fitness
Jessica A. Plante et al.
NATURE (2021)
Camostat mesylate against SARS-CoV-2 and COVID-19-Rationale, dosing and safety
Peter Breining et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2021)
SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19
Peter Chen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Chaolin Huang et al.
LANCET (2020)
Hematological findings and complications of COVID-19
Evangelos Terpos et al.
AMERICAN JOURNAL OF HEMATOLOGY (2020)
Nafamostat Mesylate Blocks Activation of SARS-CoV-2: New Treatment Option for COVID-19
Markus Hoffmann et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
Cathepsin B expression is associated with arterial stiffening and atherosclerotic vascular disease
Alexia Mareti et al.
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2020)
Glecaprevir and Maraviroc are high-affinity inhibitors of SARS-CoV-2 main protease: possible implication in COVID-19 therapy
Anas Shamsi et al.
BIOSCIENCE REPORTS (2020)
Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19
Daniel Blanco-Melo et al.
CELL (2020)
Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2
Vanessa Monteil et al.
CELL (2020)
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
Markus Hoffmann et al.
CELL (2020)
Complex Immune Dysregulation in COVID-19 Patients with Severe Respiratory Failure
Evangelos J. Giamarellos-Bourboulis et al.
CELL HOST & MICROBE (2020)
Repurposing chlorpromazine to treat COVID-19: The reCoVery study
M. Plaze et al.
ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE (2020)
Detectable 2019-nCoV viral RNA in blood is a strong indicator for the further clinical severity
Weilie Chen et al.
EMERGING MICROBES & INFECTIONS (2020)
Impact of Anti-Tumor Necrosis Factor and Thiopurine Medications on the Development of COVID-19 in Patients With Inflammatory Bowel Disease: A Nationwide Veterans Administration Cohort Study
Nabeel Khan et al.
GASTROENTEROLOGY (2020)
GI symptoms as early signs of COVID-19 in hospitalised Italian patients
Elisabetta Buscarini et al.
GUT (2020)
Decreased Mortality of COVID-19 With Renin-Angiotensin-Aldosterone System Inhibitors Therapy in Patients With Hypertension A Meta-Analysis
Xiaoming Guo et al.
HYPERTENSION (2020)
Anti-TNF-α Agents in Inflammatory Bowel Disease and Course of COVID-19
Antonio Tursi et al.
INFLAMMATORY BOWEL DISEASES (2020)
New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19?
Christian A. Devaux et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
Teicoplanin: an alternative drug for the treatment of COVID-19?
Sophie Alexandra Baron et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial
Philippe Gautret et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
A global treatments for coronaviruses including COVID-19
Bahman Yousefi et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2020)
Covid-19 and the digestive system
Sunny H. Wong et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2020)
Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells
Shutoku Matsuyama et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Arbidol combined with LPV/r versus LPV/r alone against Corona Virus Disease 2019: A retrospective cohort study
Lisi Deng et al.
JOURNAL OF INFECTION (2020)
Cytokine release syndrome in severe COVID-19
John B. Moore et al.
SCIENCE (2020)
SARS-CoV-2 productively infects human gut enterocytes
Mart M. Lamers et al.
SCIENCE (2020)
A noncompeting pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2
Yan Wu et al.
SCIENCE (2020)
Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease
Wenhao Dai et al.
SCIENCE (2020)
Structure of the RNA-dependent RNA polymerase from COVID-19 virus
Yan Gao et al.
SCIENCE (2020)
Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors
Linlin Zhang et al.
SCIENCE (2020)
Development of an inactivated vaccine candidate for SARS-CoV-2
Qiang Gao et al.
SCIENCE (2020)
DNA vaccine protection against SARS-CoV-2 in rhesus macaques
Jingyou Yu et al.
SCIENCE (2020)
Understanding the neurotropic characteristics of SARS-CoV-2: from neurological manifestations of COVID-19 to potential neurotropic mechanisms
Zhiqiang Zhou et al.
JOURNAL OF NEUROLOGY (2020)
Covid-19: what treatments are being investigated?
Elisabeth Mahase
BMJ-BRITISH MEDICAL JOURNAL (2020)
Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial
Wei Tang et al.
BMJ-BRITISH MEDICAL JOURNAL (2020)
Endothelial cell infection and endotheliitis in COVID-19
Zsuzsanna Varga et al.
LANCET (2020)
A Multibasic Cleavage Site in the Spike Protein of SARS-CoV-2 Is Essential for Infection of Human Lung Cells
Markus Hoffmann et al.
MOLECULAR CELL (2020)
A human neutralizing antibody targets the receptor-binding site of SARS-CoV-2
Rui Shi et al.
NATURE (2020)
Human neutralizing antibodies elicited by SARS-CoV-2 infection
Bin Ju et al.
NATURE (2020)
Proteomics of SARS-CoV-2-infected host cells reveals therapy targets
Denisa Bojkova et al.
NATURE (2020)
Viral and host factors related to the clinical outcome of COVID-19
Xiaonan Zhang et al.
NATURE (2020)
Structure of replicating SARS-CoV-2 polymerase
Hauke S. Hillen et al.
NATURE (2020)
Cross-neutralization ofSARS-CoV-2 by a human monoclonal SARS-CoV antibody
Dora Pinto et al.
NATURE (2020)
Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor
Jun Lan et al.
NATURE (2020)
Virological assessment of hospitalized patients with COVID-2019
Roman Woelfel et al.
NATURE (2020)
The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice
Linlin Bao et al.
NATURE (2020)
The proximal origin of SARS-CoV-2
Kristian G. Andersen et al.
NATURE MEDICINE (2020)
Infection of bat and human intestinal organoids by SARS-CoV-2
Zhou Jie et al.
NATURE MEDICINE (2020)
SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes
Waradon Sungnak et al.
NATURE MEDICINE (2020)
Renin-Angiotensin-Aldosterone System Blockers and the Risk of Covid-19
Giuseppe Mancia et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Remdesivir for the Treatment of Covid-19-Final Report
John H. Beigel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Compassionate Use of Remdesivir for Patients with Severe Covid-19
J. Grein et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Multiorgan and Renal Tropism of SARS-CoV-2
Victor G. Puelles et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Cathepsin L-selective inhibitors: A potentially promising treatment for COVID-19 patients
Tianxiao Liu et al.
PHARMACOLOGY & THERAPEUTICS (2020)
COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection
Hanny Al-Samkari et al.
BLOOD (2020)
Comparative Impacts of ACE (Angiotensin-Converting Enzyme) Inhibitors Versus Angiotensin II Receptor Blockers on the Risk of COVID-19 Mortality
Feng Zhou et al.
HYPERTENSION (2020)
The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity
Qianqian Li et al.
CELL (2020)
Development of an Inactivated Vaccine Candidate, BBIBP-CorV, with Potent Protection against SARS-CoV-2
Hui Wang et al.
CELL (2020)
A Universal Design of Betacoronavirus Vaccines against COVID-19, MERS, and SARS
Lianpan Dai et al.
CELL (2020)
Potent Neutralizing Antibodies against SARS-CoV-2 Identified by High-Throughput Single-Cell Sequencing of Convalescent Patients' B Cells
Yunlong Cao et al.
CELL (2020)
Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus
Bette Korber et al.
CELL (2020)
A SARS-CoV-2 Infection Model in Mice Demonstrates Protection by Neutralizing Antibodies
Ahmed O. Hassan et al.
CELL (2020)
A Thermostable mRNA Vaccine against COVID-19
Na-Na Zhang et al.
CELL (2020)
Treatment of SARS-CoV-2 with high dose oral zinc salts: A report on four patients
Eric Finzi
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2020)
Outcomes and biomarker analyses among patients with COVID-19 treated with interleukin 6 (IL-6) receptor antagonist sarilumab at a single institution in Italy
Vincenzo Montesarchio et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Could Ergothioneine Aid in the Treatment of Coronavirus Patients?
Irwin K. Cheah et al.
ANTIOXIDANTS (2020)
Flavonoids Activation of the Transcription Factor Nrf2 as a Hypothesis Approach for the Prevention and Modulation of SARS-CoV-2 Infection Severity
Patricia Mendonca et al.
ANTIOXIDANTS (2020)
Effect of Colchicine vs Standard Care on Cardiac and Inflammatory Biomarkers and Clinical Outcomes in Patients Hospitalized With Coronavirus Disease 2019 The GRECCO-19 Randomized Clinical Trial
Spyridon G. Deftereos et al.
JAMA NETWORK OPEN (2020)
Ribavirin, Remdesivir, Sofosbuvir, Galidesivir, and Tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (RdRp): A molecular docking study
Abdo A. Elfiky
LIFE SCIENCES (2020)
The expression of SARS-CoV-2 receptor ACE2 and CD147, and protease TMPRSS2 in human and mouse brain cells and mouse brain tissues
Jialu Qiao et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2020)
Effects of COVID-19 on the Nervous System
Costantino Iadecola et al.
CELL (2020)
Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease Severity
Carolyn Rydyznski Moderbacher et al.
CELL (2020)
SARS-CoV-2 Infects the Brain Choroid Plexus and Disrupts the Blood-CSF Barrier in Human Brain Organoids
Laura Pellegrini et al.
CELL STEM CELL (2020)
A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity
Jingyun Yang et al.
NATURE (2020)
SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19
Julian Braun et al.
NATURE (2020)
Chloroquine does not inhibit infection of human lung cells with SARS-CoV-2
Markus Hoffmann et al.
NATURE (2020)
Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques
Noe B. Mercado et al.
NATURE (2020)
SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness
Kizzmekia S. Corbett et al.
NATURE (2020)
ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques
Neeltje van Doremalen et al.
NATURE (2020)
Hydroxychloroquine use against SARS-CoV-2 infection in non-human primates
Pauline Maisonnasse et al.
NATURE (2020)
Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults
Mark J. Mulligan et al.
NATURE (2020)
SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls
Nina Le Bert et al.
NATURE (2020)
Longitudinal analyses reveal immunological misfiring in severe COVID-19
Carolina Lucas et al.
NATURE (2020)
Potently neutralizing and protective human antibodies against SARS-CoV-2
Seth J. Zost et al.
NATURE (2020)
A perspective on potential antibody-dependent enhancement of SARS-CoV-2
Ann M. Arvin et al.
NATURE (2020)
A SARS-CoV-2 surrogate virus neutralization test based on antibody-mediated blockage of ACE2-spike protein-protein interaction
Chee Wah Tan et al.
NATURE BIOTECHNOLOGY (2020)
A single-cell atlas of the peripheral immune response in patients with severe COVID-19
Aaron J. Wilk et al.
NATURE MEDICINE (2020)
Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein
Seth J. Zost et al.
NATURE MEDICINE (2020)
Immune complement and coagulation dysfunction in adverse outcomes of SARS-CoV-2 infection
Vijendra Ramlall et al.
NATURE MEDICINE (2020)
Cholesterol 25-Hydroxylase inhibits SARS-CoV-2 and other coronaviruses by depleting membrane cholesterol
Shaobo Wang et al.
EMBO JOURNAL (2020)
SARS-CoV-2 targets neurons of 3D human brain organoids
Anand Ramani et al.
EMBO JOURNAL (2020)
A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2
Xiangyang Chi et al.
SCIENCE (2020)
Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies
Alina Baum et al.
SCIENCE (2020)
Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications
Divij Mathew et al.
SCIENCE (2020)
Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model
Thomas F. Rogers et al.
SCIENCE (2020)
Engineering human ACE2 to optimize binding to the spike protein of SARS coronavirus 2
Kui K. Chan et al.
SCIENCE (2020)
Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody cocktail
Johanna Hansen et al.
SCIENCE (2020)
Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability
Philip J. M. Brouwer et al.
SCIENCE (2020)
Broad neutralization of SARS-related viruses by human monoclonal antibodies
Anna Z. Wec et al.
SCIENCE (2020)
An overview of the safety assessment of medicines currently used in the COVID-19 disease treatment
Dragana Javorac et al.
FOOD AND CHEMICAL TOXICOLOGY (2020)
Covid-19: Hydroxychloroquine does not benefit hospitalised patients, UK trial finds
Ingrid Torjesen
BMJ-BRITISH MEDICAL JOURNAL (2020)
Effect of Dexamethasone on Days Alive and Ventilator-Free in Patients With Moderate or Severe Acute Respiratory Distress Syndrome and COVID-19 The CoDEX Randomized Clinical Trial
Bruno M. Tomazini et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19 The REMAP-CAP COVID-19 Corticosteroid Domain Randomized Clinical Trial
Derek C. Angus et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses
Ugur Sahin et al.
NATURE (2020)
THE CORONAVIRUS IS MOST DEADLY IF YOU ARE OLD AND MALE
Smriti Mallapaty
NATURE (2020)
Sex differences in immune responses that underlie COVID-19 disease outcomes
Takehiro Takahashi et al.
NATURE (2020)
Vaccines targeting SARS-CoV-2 tested in humans
Kathryn M. Edwards
NATURE MEDICINE (2020)
Convalescent plasma treatment of severe COVID-19: a propensity score-matched control study
Sean T. H. Liu et al.
NATURE MEDICINE (2020)
A dynamic COVID-19 immune signature includes associations with poor prognosis
Adam G. Laing et al.
NATURE MEDICINE (2020)
Phase 1-2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine
Cheryl Keech et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Tackle the free radicals damage in COVID-19
Jun Wu
NITRIC OXIDE-BIOLOGY AND CHEMISTRY (2020)
REGN-COV2 antibodies prevent and treat SARS-CoV-2 infection in rhesus macaques and hamsters
Alina Baum et al.
SCIENCE (2020)
Ultrapotent human antibodies protect against SARS-CoV-2 challenge via multiple mechanisms
M. Alejandra Tortorici et al.
SCIENCE (2020)
Inborn errors of type I IFN immunity in patients with life-threatening COVID-19
Qian Zhang et al.
SCIENCE (2020)
Autoantibodies against type I IFNs in patients with life-threatening COVID-19
Paul Bastard et al.
SCIENCE (2020)
A single dose of an adenovirus-vectored vaccine provides protection against SARS-CoV-2 challenge
Shipo Wu et al.
NATURE COMMUNICATIONS (2020)
Expression profiling meta-analysis of ACE2 and TMPRSS2, the putative anti-inflammatory receptor and priming protease of SARS-CoV-2 in human cells, and identification of putative modulators
Eirini Gkogkou et al.
REDOX BIOLOGY (2020)
Expression of SARS-CoV-2 Entry Factors in the Pancreas of Normal Organ Donors and Individuals with COVID-19
Irina Kusmartseva et al.
CELL METABOLISM (2020)
SARS-CoV-2 Cell Entry Factors ACE2 and TMPRSS2 Are Expressed in the Microvasculature and Ducts of Human Pancreas but Are Not Enriched in β Cells
Katie C. Coate et al.
CELL METABOLISM (2020)
WHAT LANDMARK COVID VACCINE RESULTS MEAN FOR THE PANDEMIC
Ewen Callaway
NATURE (2020)
SARS-CoV-2 D614G variant exhibits efficient replication ex vivo and transmission in vivo
Yixuan J. Hou et al.
SCIENCE (2020)
ACE2: Evidence of role as entry receptor for SARS-CoV-2 and implications in comorbidities
Natalia Zamorano Cuervo et al.
ELIFE (2020)
A meta-analysis of the impact of COVID-19 on liver dysfunction
Zeng-hong Wu et al.
EUROPEAN JOURNAL OF MEDICAL RESEARCH (2020)
COVID-19-associated gastrointestinal and liver injury: clinical features and potential mechanisms
Peijie Zhong et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
Severe Acute Respiratory Syndrome Coronavirus 2 RNA Detected in Blood Donations
Le Chang et al.
EMERGING INFECTIOUS DISEASES (2020)
The use of renin angiotensin system inhibitor on mortality in patients with coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis
Raymond Pranata et al.
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2020)
Adjunct Immunotherapies for the Management of Severely Ill COVID-19 Patients
Srinivasa Reddy Bonam et al.
CELL REPORTS MEDICINE (2020)
Tocilizumab in patients with severe COVID-19: a retrospective cohort study
Giovanni Guaraldi et al.
LANCET RHEUMATOLOGY (2020)
Facts and reflections on COVID-19 and anti-hypertensives drugs
Gustavo H. Marin
DRUG DISCOVERIES AND THERAPEUTICS (2020)
Establishment and validation of a pseudovirus neutralization assay for SARS-CoV-2
Jianhui Nie et al.
EMERGING MICROBES & INFECTIONS (2020)
The Molecular Aspect of Antitumor Effects of Protease Inhibitor Nafamostat Mesylate and Its Role in Potential Clinical Applications
Xi Chen et al.
FRONTIERS IN ONCOLOGY (2019)
Revisiting the Cardiotoxic Effect of Chloroquine
Marguerite Blignaut et al.
CARDIOVASCULAR DRUGS AND THERAPY (2019)
Endocytosis regulation by autophagy proteins in MHC restricted antigen presentation
Christian W. Keller et al.
CURRENT OPINION IN IMMUNOLOGY (2018)
The vasoprotective axes of the renin-angiotensin system: Physiological relevance and therapeutic implications in cardiovascular, hypertensive and kidney diseases
Xiao C. Li et al.
PHARMACOLOGICAL RESEARCH (2017)
A pilot clinical trial of recombinant human angiotensin-converting enzyme 2 in acute respiratory distress syndrome
Akram Khan et al.
CRITICAL CARE (2017)
Renal and Bone Adverse Effects of a Tenofovir-Based Regimen in the Treatment of HIV-Infected Children: A Systematic Review
Rose I. Okonkwo et al.
DRUG SAFETY (2016)
Dysregulated Type I Interferon and Inflammatory Monocyte-Macrophage Responses Cause Lethal Pneumonia in SARS-CoV-Infected Mice
Rudragouda Channappanavar et al.
CELL HOST & MICROBE (2016)
Role of the ACE2/Angiotensin 1-7 Axis of the Renin-Angiotensin System in Heart Failure
Vaibhav B. Patel et al.
CIRCULATION RESEARCH (2016)
Ikarugamycin: A Natural Product Inhibitor of Clathrin-Mediated Endocytosis
Sarah R. Elkin et al.
TRAFFIC (2016)
Neuroprotective Mechanisms of the ACE2-Angiotensin-(1-7)-Mas Axis in Stroke
Douglas M. Bennion et al.
CURRENT HYPERTENSION REPORTS (2015)
Influenza virus-induced lung injury: pathogenesis and implications for treatment
Susanne Herold et al.
EUROPEAN RESPIRATORY JOURNAL (2015)
Angiotensin(1-7) attenuates the progression of streptozotocin-induced diabetic renal injury better than angiotensin receptor blockade
Kai Zhang et al.
KIDNEY INTERNATIONAL (2015)
Cationic nanoparticles directly bind angiotensin-converting enzyme 2 and induce acute lung injury in mice
Yang Sun et al.
PARTICLE AND FIBRE TOXICOLOGY (2015)
Standard and immunoproteasomes show similar peptide degradation specificities
Damien Zanker et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2014)
Recent developments in tubulin polymerization inhibitors: An overview
Ramandeep Kaur et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2014)
Host cell virus entry mediated by Australian bat lyssavirus G envelope glycoprotein occurs through a clathrin-mediated endocytic pathway that requires actin and Rab5
Dawn L. Weir et al.
VIROLOGY JOURNAL (2014)
Chlorpromazine versus placebo for schizophrenia
Clive E. Adams et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2014)
Protective arms of the renin-angiotensin-system in neurological disease
Colin Sumners et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2013)
Angiotensin-(1-7): beyond the cardio-renal actions
Danielle G. Passos-Silva et al.
CLINICAL SCIENCE (2013)
Novel Inhibitors of Severe Acute Respiratory Syndrome Coronavirus Entry That Act by Three Distinct Mechanisms
Adeyemi O. Adedeji et al.
JOURNAL OF VIROLOGY (2013)
Building a Better Dynasore: The Dyngo Compounds Potently Inhibit Dynamin and Endocytosis
Adam McCluskey et al.
TRAFFIC (2013)
Cathepsin B and L activity in the serum during the human aging process Cathepsin B and L in aging
Aleksandra Wyczalkowska-Tomasik et al.
ARCHIVES OF GERONTOLOGY AND GERIATRICS (2012)
ACE2 links amino acid malnutrition to microbial ecology and intestinal inflammation
Tatsuo Hashimoto et al.
NATURE (2012)
Evidence that TMPRSS2 Activates the Severe Acute Respiratory Syndrome Coronavirus Spike Protein for Membrane Fusion and Reduces Viral Control by the Humoral Immune Response
Ilona Glowacka et al.
JOURNAL OF VIROLOGY (2011)
Angiotensin-Converting Enzyme 2 (ACE2) in Disease Pathogenesis
Yumiko Imai et al.
CIRCULATION JOURNAL (2010)
Severe Acute Respiratory Syndrome (SARS) Coronavirus-Induced Lung Epithelial Cytokines Exacerbate SARS Pathogenesis by Modulating Intrinsic Functions of Monocyte-Derived Macrophages and Dendritic Cells
Tomoki Yoshikawa et al.
JOURNAL OF VIROLOGY (2009)
The sweeter side of ACE2: Physiological evidence for a role in diabetes
Sharell M. Bindom et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2009)
Genetically altered animal models for Mas and angiotensin-(1-7)
Natalia Alenina et al.
EXPERIMENTAL PHYSIOLOGY (2008)
Proteasome response to interferon-γ is altered in senescent human fibroblasts
Fiona L. L. Stratford et al.
FEBS LETTERS (2006)
Angiotensin-converting enzyme 2 in lung diseases
Keiji Kuba et al.
CURRENT OPINION IN PHARMACOLOGY (2006)
Inhibitors of cathepsin B
R. Frlan et al.
CURRENT MEDICINAL CHEMISTRY (2006)
A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury
K Kuba et al.
NATURE MEDICINE (2005)
Angiotensin-converting enzyme 2 protects from severe acute lung failure
Y Imai et al.
NATURE (2005)
Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome
CK Wong et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2004)
A human homolog of angiotensin-converting enzyme - Cloning and functional expression as a captopril-insensitive carboxypeptidase
SR Tipnis et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
